Q. Wu

Global, regional, and national estimates of target population sizes for COVID-19 vaccination

C. Viboud, M. Ajelli, X. Chen, 2020, medRxiv.

Healthcare utilization following SARS-CoV-2 infection in children and adolescents with chronic conditions: An EHR-based Cohort Study from the RECOVER Program

A. Mejias, J. Block, A. Casè, 2022, medRxiv.

Immunogenicity and safety of a third dose, and immune persistence of CoronaVac vaccine in healthy adults aged 18-59 years: interim results from a double-blind, randomized, placebo-controlled phase 2 clinical trial

K. Chu, J. Yang, X. Deng, 2021, medRxiv.

Applying Lessons Learned From COVID-19 Therapeutic Trials to Improve Future ALI/ARDS Trials

K. Sciarretta, Meghan E. Pennini, Qun Wu, 2022, Open forum infectious diseases.